Copyright Reports & Markets. All rights reserved.

Global Active Pharmaceutical Ingredient Market Research Report 2018 by Manufacturers, Regions, Types and Applications

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Definition and Specification
    • 1.2 Report Overview
      • 1.2.1 Manufacturers Overview
      • 1.2.2 Regions Overview
      • 1.2.3 Type Overview
      • 1.2.4 Application Overview
    • 1.3 Industrial Chain
      • 1.3.1 Active Pharmaceutical Ingredient Overall Industrial Chain
      • 1.3.2 Upstream
      • 1.3.3 Downstream
    • 1.4 Industry Situation
      • 1.4.1 Industrial Policy
      • 1.4.2 Product Preference
      • 1.4.3 Economic/Political Environment
    • 1.5 SWOT Analysis

    2 Market Analysis by Types

    • 2.1 Overall Market Performance
      • 2.1.1 Product Type Market Performance (Volume)
      • 2.1.2 Product Type Market Performance (Value)
    • 2.2 China Active Pharmaceutical Ingredient Market Performance
    • 2.3 USA Active Pharmaceutical Ingredient Market Performance
    • 2.4 Europe Active Pharmaceutical Ingredient Market Performance
    • 2.5 Japan Active Pharmaceutical Ingredient Market Performance
    • 2.6 Korea Active Pharmaceutical Ingredient Market Performance
    • 2.7 India Active Pharmaceutical Ingredient Market Performance
    • 2.8 Southeast Asia Active Pharmaceutical Ingredient Market Performance
    • 2.9 South America Active Pharmaceutical Ingredient Market Performance

    3 Product Application Market

    • 3.1 Overall Market Performance (Volume)
    • 3.2 China Active Pharmaceutical Ingredient Market Performance (Volume)
    • 3.3 USA Active Pharmaceutical Ingredient Market Performance (Volume)
    • 3.4 Europe Active Pharmaceutical Ingredient Market Performance (Volume)
    • 3.5 Japan Active Pharmaceutical Ingredient Market Performance (Volume)
    • 3.6 Korea Active Pharmaceutical Ingredient Market Performance (Volume)
    • 3.7 India Active Pharmaceutical Ingredient Market Performance (Volume)
    • 3.8 Southeast Asia Active Pharmaceutical Ingredient Market Performance (Volume)
    • 3.9 South America Active Pharmaceutical Ingredient Market Performance (Volume)

    4 Manufacturers Profiles/Analysis

    • 4.1 Teva
      • 4.1.1 Teva Profiles
      • 4.1.2 Teva Product Information
      • 4.1.3 Teva Active Pharmaceutical Ingredient Business Performance
      • 4.1.4 Teva Active Pharmaceutical Ingredient Business Development and Market Status
    • 4.2 Novartis
      • 4.2.1 Novartis Profiles
      • 4.2.2 Novartis Product Information
      • 4.2.3 Novartis Active Pharmaceutical Ingredient Business Performance
      • 4.2.4 Novartis Active Pharmaceutical Ingredient Business Development and Market Status
    • 4.3 Pfizer
      • 4.3.1 Pfizer Profiles
      • 4.3.2 Pfizer Product Information
      • 4.3.3 Pfizer Active Pharmaceutical Ingredient Business Performance
      • 4.3.4 Pfizer Active Pharmaceutical Ingredient Business Development and Market Status
    • 4.4 Johnson & Johnson
      • 4.4.1 Johnson & Johnson Profiles
      • 4.4.2 Johnson & Johnson Product Information
      • 4.4.3 Johnson & Johnson Active Pharmaceutical Ingredient Business Performance
      • 4.4.4 Johnson & Johnson Active Pharmaceutical Ingredient Business Development and Market Status
    • 4.5 Mylan
      • 4.5.1 Mylan Profiles
      • 4.5.2 Mylan Product Information
      • 4.5.3 Mylan Active Pharmaceutical Ingredient Business Performance
      • 4.5.4 Mylan Active Pharmaceutical Ingredient Business Development and Market Status
    • 4.6 North China Pharmaceutical Group
      • 4.6.1 North China Pharmaceutical Group Profiles
      • 4.6.2 North China Pharmaceutical Group Product Information
      • 4.6.3 North China Pharmaceutical Group Active Pharmaceutical Ingredient Business Performance
      • 4.6.4 North China Pharmaceutical Group Active Pharmaceutical Ingredient Business Development and Market Status
    • 4.7 Dr. Reddy's Laboratories
      • 4.7.1 Dr. Reddy's Laboratories Profiles
      • 4.7.2 Dr. Reddy's Laboratories Product Information
      • 4.7.3 Dr. Reddy's Laboratories Active Pharmaceutical Ingredient Business Performance
      • 4.7.4 Dr. Reddy's Laboratories Active Pharmaceutical Ingredient Business Development and Market Status
    • 4.8 Roche
      • 4.8.1 Roche Profiles
      • 4.8.2 Roche Product Information
      • 4.8.3 Roche Active Pharmaceutical Ingredient Business Performance
      • 4.8.4 Roche Active Pharmaceutical Ingredient Business Development and Market Status
    • 4.9 Aurobindo pharma
      • 4.9.1 Aurobindo pharma Profiles
      • 4.9.2 Aurobindo pharma Product Information
      • 4.9.3 Aurobindo pharma Active Pharmaceutical Ingredient Business Performance
      • 4.9.4 Aurobindo pharma Active Pharmaceutical Ingredient Business Development and Market Status
    • 4.10 Sun Pharmaceutical Industries
      • 4.10.1 Sun Pharmaceutical Industries Profiles
      • 4.10.2 Sun Pharmaceutical Industries Product Information
      • 4.10.3 Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Business Performance
      • 4.10.4 Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Business Development and Market Status
    • 4.11 Boehringer Ingelheim GmbH
    • 4.12 Bayer
    • 4.13 Pfizer
    • 4.14 Johnson & Johnson
    • 4.15 Mylan
    • 4.20 Sun Pharmaceutical Industries

    5 Market Performance for Manufacturers

    • 5.1 Global Active Pharmaceutical Ingredient Production (K Units) and Market Share by Manufacturers 2013-2018
    • 5.2 Global Active Pharmaceutical Ingredient Revenue (M USD) and Market Share by Manufacturers 2013-2018
    • 5.3 Global Active Pharmaceutical Ingredient Price (USD/Unit) of Manufacturers 2013-2018
    • 5.4 Global Active Pharmaceutical Ingredient Gross Margin of Manufacturers 2013-2018
    • 5.5 Market Concentration

    6 Global Active Pharmaceutical Ingredient Market Performance (Production Point)

    • 6.1 Global Active Pharmaceutical Ingredient Production (K Units) and Market Share by Regions 2013-2018
    • 6.2 Global Active Pharmaceutical Ingredient Revenue (M USD) and Market Share by Regions 2013-2018
    • 6.3 Global Active Pharmaceutical Ingredient Price (USD/Unit) by Regions 2013-2018
    • 6.4 Global Active Pharmaceutical Ingredient Gross Margin by Regions 2013-2018

    7 Development Trend for Regions (Production Point)

    • 7.1 Global Active Pharmaceutical Ingredient Production (K Units), Revenue (&$B$8&) and Growth Rate 2013-2018
    • 7.2 China Active Pharmaceutical Ingredient Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
    • 7.3 USA Active Pharmaceutical Ingredient Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
    • 7.4 Europe Active Pharmaceutical Ingredient Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
    • 7.5 Japan Active Pharmaceutical Ingredient Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
    • 7.6 Korea Active Pharmaceutical Ingredient Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
    • 7.7 India Active Pharmaceutical Ingredient Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
    • 7.8 Southeast Asia Active Pharmaceutical Ingredient Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
    • 7.9 South America Active Pharmaceutical Ingredient Production (K Units), Revenue (M USD) and Growth Rate 2013-2018

    8 Global Active Pharmaceutical Ingredient Market Performance (Consumption Point)

    • 8.1 Global Active Pharmaceutical Ingredient Consumption and Market Share by Regions 2013-2018
    • 8.2 Global Active Pharmaceutical Ingredient Consumption Value and Market Share by Regions 2013-2018
    • 8.3 Global Active Pharmaceutical Ingredient Price (USD/Unit) by Regions 2013-2018

    9 Development Trend for Regions (Sales Point)

    • 9.1 Global Active Pharmaceutical Ingredient Sales and Growth, Sales Value and Growth Rate2013-2018
    • 9.2 China Active Pharmaceutical Ingredient Sales and Growth, Sales Value and Growth Rate2013-2018
    • 9.3 USA Active Pharmaceutical Ingredient Sales and Growth, Sales Value and Growth Rate2013-2018
    • 9.4 Europe Active Pharmaceutical Ingredient Sales and Growth, Sales Value and Growth Rate2013-2018
    • 9.5 Japan Active Pharmaceutical Ingredient Sales and Growth, Sales Value and Growth Rate2013-2018
    • 9.6 Korea Active Pharmaceutical Ingredient Sales and Growth, Sales Value and Growth Rate2013-2018
    • 9.7 India Active Pharmaceutical Ingredient Sales and Growth, Sales Value and Growth Rate2013-2018
    • 9.8 Southeast Asia Active Pharmaceutical Ingredient Sales and Growth, Sales Value and Growth Rate2013-2018
    • 9.9 South America Active Pharmaceutical Ingredient Sales and Growth, Sales Value and Growth Rate2013-2018

    10 Upstream Source, Technology and Cost

    • 10.1 Upstream Source
    • 10.2 Technology
    • 10.3 Cost

    11 Channel Analysis

    • 11.1 Market Channel
    • 11.2 Distributors

    12 Consumer Analysis

    • 12.1 Chemical Industry
    • 12.2 Deodorant Industry
    • 12.3 Dailylife Industry

    13 Market Forecast 2019-2024

    • 13.1 Production (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
      • 13.1.1 Global Active Pharmaceutical Ingredient Production (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
      • 13.1.2 Global Active Pharmaceutical Ingredient Production (K Units) and Growth Rate 2019-2024
      • 13.1.3 China Active Pharmaceutical Ingredient Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 13.1.4 USA Active Pharmaceutical Ingredient Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 13.1.5 Europe Active Pharmaceutical Ingredient Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 13.1.6 Japan Active Pharmaceutical Ingredient Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 13.1.7 Korea Active Pharmaceutical Ingredient Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 13.1.8 India Active Pharmaceutical Ingredient Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 13.1.9 Southeast Asia Active Pharmaceutical Ingredient Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 13.1.10 South America Active Pharmaceutical Ingredient Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
    • 13.2 Sales, Sales Value and Growth Rate 2019-2024
      • 13.2.1 Global Active Pharmaceutical Ingredient Consumption and Market Share by Regions 2019-2024
      • 13.2.2 Global Active Pharmaceutical Ingredient Sales, Sales Value and Growth Rate 2019-2024
      • 13.2.3 China Active Pharmaceutical Ingredient Sales, Sales Value and Growth Rate 2019-2024
      • 13.2.4 USA Active Pharmaceutical Ingredient Sales, Sales Value and Growth Rate 2019-2024
      • 13.2.5 Europe Active Pharmaceutical Ingredient Sales, Sales Value and Growth Rate 2019-2024
      • 13.2.6 Japan Active Pharmaceutical Ingredient Sales, Sales Value and Growth Rate 2019-2024
      • 13.2.7 Korea Active Pharmaceutical Ingredient Sales, Sales Value and Growth Rate 2019-2024
      • 13.2.8 India Active Pharmaceutical Ingredient Sales, Sales Value and Growth Rate 2019-2024
      • 13.2.9 Southeast Asia Active Pharmaceutical Ingredient Sales, Sales Value and Growth Rate 2019-2024
      • 13.2.10 South America Active Pharmaceutical Ingredient Sales, Sales Value and Growth Rate 2019-2024
    • 13.3 Production (K Units), Revenue (M USD) by Types 2019-2024
      • 13.3.1 Overall Market Performance
      • 13.3.2 Synthetic API Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 13.3.3 Biotech API Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 13.3.4 Other Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
    • 13.4 Sales by Application 2019-2024
      • 13.4.1 Overall Market Performance
      • 13.4.2 Chemical Sales and and Growth Rate 2019-2024
      • 13.4.3 Deodorant Sales and and Growth Rate 2019-2024
      • 13.4.4 Dailylife Sales and and Growth Rate 2019-2024
    • 13.5 Price (USD/Unit) and Gross Profit
      • 13.5.1 Global Active Pharmaceutical Ingredient Price (USD/Unit) Trend 2019-2024
      • 13.5.2 Global Active Pharmaceutical Ingredient Gross Profit Trend 2019-2024

    14 Conclusion

    Geographically, global Active Pharmaceutical Ingredient market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    Teva
    Novartis
    Pfizer
    Johnson & Johnson
    Mylan
    North China Pharmaceutical Group
    Dr. Reddy's Laboratories
    Roche
    Aurobindo pharma
    Sun Pharmaceutical Industries
    Boehringer Ingelheim GmbH
    Bayer
    BASF
    DSM
    Zhejiang Medicine

    On the basis of product, we research the production, revenue, price, market share and growth rate, primarily split into
    Synthetic API
    Biotech API
    Other
    For the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Active Pharmaceutical Ingredient for each application, including
    Chemical
    Deodorant
    Dailylife
    Production, consumption, revenue, market share and growth rate are the key targets for Active Pharmaceutical Ingredient from 2013 to 2024 (forecast) in these regions
    China
    USA
    Europe
    Japan
    Korea
    India
    Southeast Asia
    South America

    If you have any special requirements, please let us know and we will offer you the report as you want.

    Buy now